{
  "id": "adv_mhgap#risk_safety_458e31f4",
  "content": "established and regulated national framework. It is characterized by the acting benzodiazepine and gradually decreasing the dose, tapered over\nprescription of long-acting opioid agonists (or partial agonists), such as 8-12 weeks, and in conjunction with psychosocial support. More rapid\nmethadone or buprenorphine, generally on a daily, supervised basis. tapering is possible only if the person is in an inpatient setting in a\nThere is strong evidence that agonist maintenance treatment with hospital or detoxification facility.\nmethadone or buprenorphine effectively reduces illicit drug use, the »\nIf severe, uncontrolled benzodiazepine withdrawal develops or occurs\nspread of HIV, mortality, and criminality, as well as improving physical\ndue to a sudden or unplanned cessation, consult a specialist or other\nhealth, mental health, and social functioning.\navailable resource person immediately to start a high-dose benzodiazepine\n»\nMonitoring: Medications used for opioid agonist maintenance treatment sedation regime and to hospitalise the person. Be cautious with\nare open to misuse and diversion, hence, programmes should use various unsupervised dispensing of benzodiazepines to unknown patients.\nmethods of limiting the risk of diversion, including supervised\nconsumption.\n»\nFor more details please see Table 1.\nPSYCHOSOCIAL INTERVENTIONS",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "work",
      "risk_safety",
      "referral",
      "management",
      "psychoeducation"
    ],
    "is_clinical": true,
    "is_advice": true
  },
  "index_text": "General — Risk Safety established and regulated national framework. It is characterized by the acting benzodiazepine and gradually decreasing the dose, tapered over\nprescription of long-acting opioid agonists (or partial agonists), such as 8-12 weeks, and in conjunction with psychosocial support. More rapid\nmethadone or buprenorphine, generally on a daily, supervised basis. tapering is possible only if the person is in an inpatient setting in a\nThere is strong evidence that agonist maintenance treatment with hospital or detoxification facility.\nmethadone or buprenorphine effectively reduces illicit drug use, the »\nIf severe, uncontrolled benzodiazepine withdrawal develops or occurs\nspread of HIV, mortality, and criminality, as well as improving physical\ndue to a sudden or unplanned cessation, consult a specialist or other\nhealth, mental health, and social functioning.\navailable resource person immediately to start a high-dose benzodiazepine\n»\nMonitoring: Medications used for opioid agonist maintenance treatment sedation regime and to hospitalise the person. Be cautious with\nare open to misuse and diversion, hence, programmes should use various unsupervised dispensing of benzodiazepines to unknown patients.\nmethods of limiting the risk of diversion, including supervised\nconsumption.\n»\nFor more details please see Table 1.\nPSYCHOSOCIAL INTERVENTIONS Established and regulated national framework. it is characterized by the acting benzodiazepine and gradually decreasing the dose, tapered over\nprescription of long-acting opioid agonists (or partial agonists), such as 8-..."
}